loading page

Oncolytic effect of SARS-CoV-2 in a patient with mycosis fungoides (MF): a case report
  • +1
  • Laya Ohadi,
  • Fatemeh Hosseinzadeh,
  • Sahar Dadkhahfar,
  • Soheila Nasiri
Laya Ohadi
Shahid Beheshti University of Medical Sciences
Author Profile
Fatemeh Hosseinzadeh
Shahid Beheshti University of Medical Sciences
Author Profile
Sahar Dadkhahfar
Shahid Beheshti University of Medical Sciences
Author Profile
Soheila Nasiri
Skin Research Center Shahid Beheshti University of Medical Sciences
Author Profile

Abstract

The most common variant of cutaneous T-cell lymphomas (CTCL) is mycosis fungoides (MF).The spontaneous regression (SR) of MF is rare. Here, we are reporting an interesting case of refractory MF after COVID-19. The SARS-CoV-2 could be an essential component in the improvement of clinical features related to MF.

Peer review status:IN REVISION

08 Jan 2022Submitted to Clinical Case Reports
11 Jan 2022Assigned to Editor
11 Jan 2022Submission Checks Completed
13 Jan 2022Reviewer(s) Assigned
16 Jan 2022Review(s) Completed, Editorial Evaluation Pending
24 Jan 2022Editorial Decision: Revise Minor